Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Inventory (2023 - 2025)

Verrica Pharmaceuticals has reported Inventory over the past 3 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Inventory at $2.2 million for Q4 2025, down 9.22% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (down 9.22% YoY), and the annual figure for FY2025 was $2.2 million, down 9.22%.
  • Inventory for Q4 2025 was $2.2 million at Verrica Pharmaceuticals, down from $2.3 million in the prior quarter.
  • Over the last five years, Inventory for VRCA hit a ceiling of $2.7 million in Q2 2024 and a floor of $279000.0 in Q3 2023.
  • Median Inventory over the past 3 years was $2.5 million (2024), compared with a mean of $2.1 million.
  • Biggest five-year swings in Inventory: surged 826.16% in 2024 and later dropped 10.84% in 2025.
  • Verrica Pharmaceuticals' Inventory stood at $1.0 million in 2023, then skyrocketed by 141.0% to $2.5 million in 2024, then decreased by 9.22% to $2.2 million in 2025.
  • The last three reported values for Inventory were $2.2 million (Q4 2025), $2.3 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.